Discovery of bacterial defense and phage counter-defense strategies
细菌防御和噬菌体反防御策略的发现
基本信息
- 批准号:10439572
- 负责人:
- 金额:$ 49.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:Antibiotic ResistanceAntibioticsBacteriaBacterial InfectionsBacteriophage lambdaBacteriophagesBasic ScienceBiological AssayBiologyCRISPR/Cas technologyCell SurvivalDNADataDatabasesDrug resistanceEcosystemEscherichia coliEvolutionGenesGeneticGenomeGenomic IslandsGenomicsHorizontal Gene TransferHumanHuman MicrobiomeImmuneImmunityInfectionKnowledgeLibrariesLinkMetagenomicsMethodsModificationMolecularMulti-Drug ResistanceMutationNatureOpen Reading FramesOutcomePathogenesisPhenotypePlasmidsProphagesProteinsResistanceResourcesSchemeSourceSurveysSystemTechniquesTestingTherapeuticTimeToxinVirulenceVirulence Factorsalpha Toxinarms racebaseconventional therapyflexibilitygain of functionhuman pathogeninfectious disease treatmentinhibitorinsightmetagenomemicrobialmolecular arraynovelnovel strategiespathogenreceptorresistance generesponsesuccess
项目摘要
PROJECT SUMMARY
Bacteria encode a diverse array of molecular systems to defend against infecting phages. In response,
phages have devised many counter-defense strategies to overcome this immunity and re-establish infection.
Mounting evidence suggests that most bacterial defense systems and phage counter-defenses in nature have
not been identified. This is a major knowledge gap because the interplay between these systems often
determines whether a phage successfully infects its bacterial host. These phage infections, in turn, have major
impacts on the evolution and treatment of infectious disease. For instance, pathogenesis in bacteria often
evolves due to the integration of a prophage that expresses a toxin or other virulence factor. At the same time,
phages are increasingly viewed as potential therapeutics to treat bacterial infections, especially in cases where
multi-drug resistance renders conventional treatments unsuccessful. Thus, it is important to better understand
the natural diversity of bacterial defense and phage counter-defense systems. To meet this need, we will devise
new high-throughput functional selections to find defense and counter-defense systems in microbial ecosystems
and in libraries of synthesized phage open reading frames. This functional approach does not rely on sequence
similarity to predict defense and counter-defense systems, so overcomes the limitations of conventional,
homology-based discovery methods. This strategy, therefore, is expected to identify many new defense and
counter-defense genes beyond what is known currently. It is especially valuable for examining functions encoded
in phage genomes and bacterial genomic islands, as most genes from these sources are of unknown function.
Since nearly all bacteria should encode anti-phage defense systems, and almost all phages will encode counter-
defense strategies, we expect to make many new discoveries. Because these discoveries are predicted to be
novel, we will use a combination of genetic and functional assays to describe their mechanisms of action. We
will use Escherichia coli as a host for our functional selections, not only because this will allow us to construct
large functional libraries, but also because virulence in this pathogen is driven by prophage-expressed toxins
and because its phages are among those used most commonly to develop phage therapies. Thus, our findings
will not only be broadly relevant to pathogenesis and phage therapy across bacteria, but also will yield these
insights specifically in the context of this important human pathogen.
项目摘要
细菌编码了一系列不同的分子系统来抵御细菌的感染。在答复中,
免疫系统已经设计了许多反防御策略来克服这种免疫力并重新建立感染。
越来越多的证据表明,自然界中大多数细菌防御系统和噬菌体反防御系统都具有
未被确认。这是一个重大的知识差距,因为这些系统之间的相互作用往往
决定了噬菌体是否能成功感染宿主细菌。这些噬菌体感染,反过来,有重大的
对传染病的演变和治疗的影响。例如,细菌的致病机理通常
由于表达毒素或其它毒力因子的原噬菌体的整合而进化。与此同时,
抗生素越来越被视为治疗细菌感染的潜在疗法,特别是在以下情况下,
多重抗药性使得常规治疗不成功。因此,更好地理解
细菌防御和噬菌体反防御系统的天然多样性。为了满足这一需求,我们将
新的高通量功能选择,以发现微生物生态系统中的防御和反防御系统
和在合成噬菌体开放阅读框的文库中。这种功能方法不依赖于顺序
预测防御和反防御系统的相似性,因此克服了传统的局限性,
基于同源性的发现方法因此,这一战略预计将确定许多新的防御措施,
反防御基因超出了目前已知的。它对于检查编码的函数特别有价值
在噬菌体基因组和细菌基因组岛中,因为来自这些来源的大多数基因的功能未知。
由于几乎所有的细菌都应该编码抗噬菌体防御系统,而且几乎所有的噬菌体都将编码反噬菌体防御系统,
防御策略,我们期待有许多新的发现。因为这些发现被预测为
新的,我们将使用遗传和功能测定的组合来描述其作用机制。我们
我们将使用大肠杆菌作为我们功能选择的宿主,不仅因为这将使我们能够构建
大的功能文库,而且还因为这种病原体的毒力是由原噬菌体表达的毒素驱动的
并且因为它的噬菌体是最常用于开发噬菌体疗法的噬菌体。因此,我们的发现
不仅与细菌的发病机制和噬菌体治疗广泛相关,而且还将产生这些
特别是在这种重要的人类病原体的背景下。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kevin J Forsberg其他文献
Kevin J Forsberg的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kevin J Forsberg', 18)}}的其他基金
Discovery of bacterial defense and phage counter-defense strategies
细菌防御和噬菌体反防御策略的发现
- 批准号:
10750038 - 财政年份:2021
- 资助金额:
$ 49.2万 - 项目类别:
Discovery of bacterial defense and phage counter-defense strategies
细菌防御和噬菌体反防御策略的发现
- 批准号:
10649493 - 财政年份:2021
- 资助金额:
$ 49.2万 - 项目类别:
Discovery of bacterial defense and phage counter-defense strategies
细菌防御和噬菌体反防御策略的发现
- 批准号:
10049809 - 财政年份:2021
- 资助金额:
$ 49.2万 - 项目类别:
Discovery of bacterial defense and phage counter-defense strategies
细菌防御和噬菌体反防御策略的发现
- 批准号:
10772250 - 财政年份:2021
- 资助金额:
$ 49.2万 - 项目类别:
相似海外基金
DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
- 批准号:
EP/Y023528/1 - 财政年份:2024
- 资助金额:
$ 49.2万 - 项目类别:
Research Grant
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
- 批准号:
BB/Y007611/1 - 财政年份:2024
- 资助金额:
$ 49.2万 - 项目类别:
Research Grant
Hitting bacteria with a Bam: Lectin-Like Antimicrobials as New Antibiotics
用 Bam 击中细菌:凝集素类抗菌剂作为新型抗生素
- 批准号:
DP230102150 - 财政年份:2023
- 资助金额:
$ 49.2万 - 项目类别:
Discovery Projects
“L-form” bacteria: basic science, antibiotics, evolution and biotechnology
L 型细菌:基础科学、抗生素、进化和生物技术
- 批准号:
FL210100071 - 财政年份:2022
- 资助金额:
$ 49.2万 - 项目类别:
Australian Laureate Fellowships
Systematic identification of synthetic interactions in bacteria towards the next-generation of antibiotics
系统鉴定细菌与下一代抗生素的合成相互作用
- 批准号:
468567 - 财政年份:2022
- 资助金额:
$ 49.2万 - 项目类别:
Operating Grants
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants
使用抗生素佐剂重新利用革兰氏阳性抗生素治疗革兰氏阴性菌
- 批准号:
10708102 - 财政年份:2022
- 资助金额:
$ 49.2万 - 项目类别:
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants
使用抗生素佐剂重新利用革兰氏阳性抗生素治疗革兰氏阴性菌
- 批准号:
10587015 - 财政年份:2022
- 资助金额:
$ 49.2万 - 项目类别:
Isolation, identification and characterization of potentially novel antibiotics from rhizospheric bacteria without detectable in vitro resistance
从根际细菌中分离、鉴定和表征潜在的新型抗生素,且体外未检测到耐药性
- 批准号:
10581945 - 财政年份:2021
- 资助金额:
$ 49.2万 - 项目类别:
Developing novel antibiotics from natural products against resistant bacteria
从天然产物中开发针对耐药细菌的新型抗生素
- 批准号:
2599490 - 财政年份:2021
- 资助金额:
$ 49.2万 - 项目类别:
Studentship
Isolation, identification and characterization of potentially novel antibiotics from rhizospheric bacteria without detectable in vitro resistance
从根际细菌中分离、鉴定和表征潜在的新型抗生素,且体外未检测到耐药性
- 批准号:
10358855 - 财政年份:2021
- 资助金额:
$ 49.2万 - 项目类别:














{{item.name}}会员




